ATE54153T1 - Androstan-17beta-carbonsaeureester, ein prozess und zwischenprodukte fuer ihre herstellung, kompositionen und methode zur behandlung inflammatorischer zustaende. - Google Patents

Androstan-17beta-carbonsaeureester, ein prozess und zwischenprodukte fuer ihre herstellung, kompositionen und methode zur behandlung inflammatorischer zustaende.

Info

Publication number
ATE54153T1
ATE54153T1 AT84850348T AT84850348T ATE54153T1 AT E54153 T1 ATE54153 T1 AT E54153T1 AT 84850348 T AT84850348 T AT 84850348T AT 84850348 T AT84850348 T AT 84850348T AT E54153 T1 ATE54153 T1 AT E54153T1
Authority
AT
Austria
Prior art keywords
sub
hydrogen
treatment
compounds
preparation
Prior art date
Application number
AT84850348T
Other languages
English (en)
Inventor
Ralph Lennart Brattsand
Bror Arne Thalen
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Application granted granted Critical
Publication of ATE54153T1 publication Critical patent/ATE54153T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT84850348T 1983-11-18 1984-11-09 Androstan-17beta-carbonsaeureester, ein prozess und zwischenprodukte fuer ihre herstellung, kompositionen und methode zur behandlung inflammatorischer zustaende. ATE54153T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8306370A SE8306370D0 (sv) 1983-11-18 1983-11-18 Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions
EP84850348A EP0143764B1 (de) 1983-11-18 1984-11-09 Androstan-17beta-Carbonsäureester, ein Prozess und Zwischenprodukte für ihre Herstellung, Kompositionen und Methode zur Behandlung inflammatorischer Zustände

Publications (1)

Publication Number Publication Date
ATE54153T1 true ATE54153T1 (de) 1990-07-15

Family

ID=20353384

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84850348T ATE54153T1 (de) 1983-11-18 1984-11-09 Androstan-17beta-carbonsaeureester, ein prozess und zwischenprodukte fuer ihre herstellung, kompositionen und methode zur behandlung inflammatorischer zustaende.

Country Status (6)

Country Link
US (1) US4820700A (de)
EP (1) EP0143764B1 (de)
JP (1) JPS60123496A (de)
AT (1) ATE54153T1 (de)
DE (1) DE3482588D1 (de)
SE (1) SE8306370D0 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8501693D0 (sv) * 1985-04-04 1985-04-04 Draco Ab Novel 16,17-acetalsubstituted androstane-17beta-carboxylic acid esters
US5643602A (en) * 1989-11-22 1997-07-01 Astra Aktiebolag Oral composition for the treatment of inflammatory bowel disease
SE8903914D0 (sv) 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
KR960700266A (ko) * 1993-01-08 1996-01-19 클래스 빌헬름슨 신규 결장- 또는 회장-특이성 스테로이드 유도체(Novel Colon-or lleum-Specific Steroid Derivatives)
US6166024A (en) * 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
TR199801247T2 (xx) * 1995-12-29 1998-11-23 Glaxo Group Limited 17.beta.-karboksi, karbotio t�revleri ve amid androstan t�revleri.
AU763307B2 (en) * 1998-02-04 2003-07-17 Charlotte-Mecklenburg Hospital Authority Androsterone derivatives for inhibiting DNA binding of AP-1 and airway smooth muscle proliferation
NZ584160A (en) * 2007-10-04 2011-05-27 Astrazeneca Ab Steroidal [3,2-c] pyrazole compounds, with glucocorticoid activity
CN101945885A (zh) * 2007-12-20 2011-01-12 阿斯利康(瑞典)有限公司 用作糖皮质激素受体激动剂的甾类衍生物
WO2009108118A1 (en) * 2008-02-27 2009-09-03 Astrazeneca Ab 16 alpha, 17 alpa-acetal glucocorticosteroidal derivatives and their use
UY32521A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Combinación para emplear en el tratamiento de enfermedades respiratorias
UY32525A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticosteroides
UY32523A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticosteroides
UY32520A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticoesteroides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1438940A (en) * 1972-07-19 1976-06-09 Glaxo Lab Ltd 17beta-haloalkoxycarbonyl-17alpha-oxysteroids
CH628355A5 (de) * 1976-02-24 1982-02-26 Ciba Geigy Ag Verfahren zur herstellung neuer androstadien-17beta-carbonsaeuren und ihrer ester und salze.
CH614960A5 (de) * 1976-04-15 1979-12-28 Ciba Geigy Ag
CH634081A5 (en) * 1977-04-13 1983-01-14 Ciba Geigy Ag Process for the preparation of novel androstadiene-17beta-carboxylic acid esters
US4198336A (en) * 1978-04-05 1980-04-15 Syntex (U.S.A.) Inc. Chemical process for preparing androsta-4-ene 17α-carboxylic acids
US4198403A (en) * 1978-04-05 1980-04-15 Syntex (U.S.A.) Inc. 17 Beta-thiocarboxylic acid esters of 4-halo-3-oxoandrost-4-enes

Also Published As

Publication number Publication date
JPH0533714B2 (de) 1993-05-20
US4820700A (en) 1989-04-11
SE8306370D0 (sv) 1983-11-18
EP0143764B1 (de) 1990-06-27
EP0143764A1 (de) 1985-06-05
DE3482588D1 (de) 1990-08-02
JPS60123496A (ja) 1985-07-02

Similar Documents

Publication Publication Date Title
ATE54153T1 (de) Androstan-17beta-carbonsaeureester, ein prozess und zwischenprodukte fuer ihre herstellung, kompositionen und methode zur behandlung inflammatorischer zustaende.
HK57197A (en) Naphthalene derivatives procedure for their preparation and pharmaceutical compositions containing them
ATE34980T1 (de) Blutdruck herabsetzende piperazin-derivate.
FR2378001A1 (fr) Nouveaux cyclohexylcyclohexanes utiles comme derives cristallins liquides
FR2383171A1 (fr) Derives de thiopropanoylaminoacides utiles comme hypotenseurs
ES479272A1 (es) Un procedimiento para la preparacion de esteres de acidos 17beta-tiocarboxilicos de 4-halo-3-oxoandrost-4-enos.
KR930002311A (ko) N-페닐티오우레아 유도체 및 그의 약학적 용도
KR900016178A (ko) 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물
FR2400008A1 (fr) Agents anti-hypertensifs
ES470916A1 (es) Ÿun procedimiento para la preparacion de derivados de acidos4-hidroxi-2-quinolinon-3-carboxilicosŸ
DK535384A (da) 1,3-dioxan-4-yl-alken- og alkansyrer, fremgangsmaader til fremstilling heraf og midler med indhold heraf
DE3174132D1 (en) New ethenylimidazole derivatives, processes for their preparation and pharmaceutical compositions containing them; intermediates, useful in their preparation and a process for the preparation thereof
MY102056A (en) Novel 16, 17-acetalsubstituted androstane-17b- carboxylic acid esters
Weilmuenster et al. The Preparation and Properties of Some Furfuryl Quaternary Ammonium Compounds1, 2
FR2566407B1 (fr) Nouveaux derives de l'isoxazoloquinoleine, procede de preparation, application a titre de medicaments, et compositions les renfermant
DE3175674D1 (en) Novel dibenzoxepins, their preparation, compositions containing them and the use of dibenzoxepins in the treatment of allergic conditions
ATE7498T1 (de) Cycloheptindolderivate und ihre saeureadditionssalze, ihre herstellung, ihre verwendung als arzneimittel und sie enthaltende zusammensetzungen.
SU1227628A1 (ru) Способ получени 1-ацетил-5-аминопиразолидинов
ZA807790B (en) 2-phenylamino-imidazolines-(2),compositions thereof and process for the preparation thereof
IE800588L (en) Piperidinothiazolidines
DE69105108D1 (de) Substituierte N-[Phenyl-(thioxomethyl)]-morpholinderivate, Verfahren zu ihrer Herstellung, diese enthaltende Zusammensetzung und ihre Verwendung.
ES536139A0 (es) Procedimiento para la preparacion de quinolinonas-4
TH1269A (th) ส่วนผสมยากำจัดวัชชพืชและกรรมวิธี
ATE15669T1 (de) Derivate der 3-amino-1-heteroaryloxy-propanolklasse, ihre verwendung in der therapie und ein verfahren zu ihrer herstellung.
TH4052A (th) 16,17-แอเซแทลซับสทิทิวเทด แอนโครสเทน-17(อักษรเคมี)-คาร์บอนซิลิค แอซิด เอสเทอร์ ชนิดใหม่

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time